These results highlight that tumors from ccRCC patients expressing primary cilia with a GLI1+/IFT20+ signature but not VDAC1-ΔC are significantly more aggressive and are characterized by a poor prognosis. Here, IFT20 is linked to nonpapillary renal cell carcinoma.